Multiple sclerosis is not associated with an increased risk for severe COVID-19: a nationwide retrospective cross-sectional study from Germany.

Daniel RichterSimon FaissnerDirk BartigLars TöngesKerstin HellwigIlya AyzenbergChristos KrogiasRalf Gold

Published in: Neurological research and practice (2021)

Although there might be differences in risk within the MS patients' population, this large-scale nationwide analysis found no evidence for a worse outcome of COVID-19 in patients with comorbid MS compared to non-MS individuals.

Keyphrases

multiple sclerosis
coronavirus disease
mass spectrometry
sars cov
ms ms
end stage renal disease
cross sectional
ejection fraction
newly diagnosed
chronic kidney disease
white matter
peritoneal dialysis
prognostic factors
early onset
respiratory syndrome coronavirus